Metformin increases fasting glucose clearance and endogenous glucose production in non-diabetic individuals.
- Published in:
- Diabetologia, 2020, v. 63, n. 2, p. 444, doi. 10.1007/s00125-019-05042-1
- By:
- Publication type:
- Article
Works matching AU MCCREIGHT, LAURA J.
Results: 4
1
2
1122-P: Physiological Effects of Pioglitazone in Ataxia-Telangiectasia.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1122-P
- By:
- Publication type:
- Article
3
1121-P: Metformin Intolerance, Proton Pump Inhibitors, and OCT1 Variation: A Recruit-by-Genotype, Randomised Controlled Trial (ImpOCT).
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1121-P
- By:
- Publication type:
- Article
4
Pharmacokinetics of metformin in patients with gastrointestinal intolerance.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 7, p. 1593, doi. 10.1111/dom.13264
- By:
- Publication type:
- Article